Aker BP ASA
Aker BP ASA (DETNF) Financial Performance & Income Statement Overview
Analyze Aker BP ASA (DETNF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Aker BP ASA (DETNF) Income Statement & Financial Overview
Explore comprehensive income reports for Aker BP ASA DETNF, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.03B | $2.82B | $3.38B | $3.05B |
| Cost of Revenue | $832.60M | $800.00M | $277.90M | $872.10M |
| Gross Profit | $2.19B | $2.02B | $3.10B | $2.18B |
| Gross Profit Ratio | $0.72 | $0.72 | $0.92 | $0.71 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $107.60M | $68.20M |
| Operating Expenses | $114.10M | $327.40M | $803.30M | $57.30M |
| Total Costs & Expenses | $946.70M | $1.13B | $1.08B | $929.40M |
| Interest Income | $47.70M | $42.80M | $13.00M | $36.70M |
| Interest Expense | $7.60M | $12.40M | $0.00 | $21.40M |
| Depreciation & Amortization | $603.40M | $613.90M | $616.50M | $592.50M |
| EBITDA | $2.66B | $2.25B | $2.95B | $2.70B |
| EBITDA Ratio | $0.88 | $0.80 | $0.87 | $0.97 |
| Operating Income | $2.08B | $1.69B | $2.30B | $2.19B |
| Operating Income Ratio | $0.69 | $0.60 | $0.68 | $0.72 |
| Other Income/Expenses (Net) | -$26.90M | -$67.80M | -$15.90M | -$104.20M |
| Income Before Tax | $2.05B | $1.63B | $2.28B | $2.09B |
| Income Before Tax Ratio | $0.68 | $0.58 | $0.68 | $0.68 |
| Income Tax Expense | $1.49B | $1.45B | $1.72B | $1.56B |
| Net Income | $561.80M | $173.40M | $561.30M | $531.30M |
| Net Income Ratio | $0.19 | $0.06 | $0.17 | $0.17 |
| EPS | $0.89 | $0.27 | $0.89 | $0.84 |
| Diluted EPS | $0.89 | $0.27 | $0.89 | $0.84 |
| Weighted Avg Shares Outstanding | $630.79M | $630.79M | $631.16M | $631.29M |
| Weighted Avg Shares Outstanding (Diluted) | $630.79M | $630.79M | $631.16M | $631.29M |
The company's financials show resilient growth, with revenue advancing from $3.05B in Q1 2024 to $3.03B in Q4 2024. Gross profit remained healthy with margins at 72% in Q4 2024 compared to 71% in Q1 2024. Operating income hit $2.08B last quarter, sustaining a consistent 69% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $2.66B. Net income rose to $561.80M, while earnings per share reached $0.89. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan